Guardant Health: A Rollercoaster Ride for Investors
Guardant Health has grabbed attention in the investment world, but opinions are split. Some financial heavyweights, like J. P. Morgan and Canaccord Genuity, are bullish about its prospects. They believe the company's stock is a solid buy, with J. P. Morgan even setting a price target close to its cu